Inventor
GERMAINE FUH
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07KPeptides30%
A61KPreparations for medical, dental or toiletry purposes25%
C12NMicroorganisms or enzymes10%
C40BCombinatorial chemistry5%
PatentTitleYear
12,121,586Optimized variants of anti-VEGF antibodies202412,060,426Anti-ULBP6 antibodies202412,006,360Dual specific antibodies for binding interleukin 4 (IL4) and interleukin 5 (IL5)202411,891,437Methods of treating ocular disorders by administering a VEGF-binding antibody covalently linked to a hyaluronic acid polymer202411,851,501Multispecific antibodies202311,512,143Anti-HtrA1 antibodies and methods of use thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to GENENTECH INC (5)· patent assignee history
2022–2024Based in US· patent location history
2024Patents assigned to 23ANDME INC (1)· patent assignee history
2024Patents assigned to GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 3 LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENENTECH INC | 5 | 2022–2024 |
| 23ANDME INC | 1 | 2024 |
| GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 3 LTD | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2024 |